Literature DB >> 4714959

The fibrinolytic enzyme system in hypertension.

B Bennett, D Ogston, G P Crawford, A S Douglas.   

Abstract

Fibrinogen, fibrinogen-related antigen (FR-antigen), and components of the fibrinolytic enzyme system were measured in patients with essential hypertension, renal disease with and without hypertension, and normal subjects. Essential hypertension was associated with a decrease in plasminogen activator and an increase in FR-antigen. In renal disease these changes were accompanied by increases in plasminogen activation inhibitor, alpha(2)-macroglobulin, alpha(1)-antitrypsin, and fibrinogen.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4714959      PMCID: PMC477733          DOI: 10.1136/jcp.26.5.351

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  15 in total

1.  PLASMA FIBRINOLYTIC ACTIVITY IN RENAL DISEASE.

Authors:  G P MCNICOL; A A BARAKAT; A S DOUGLAS
Journal:  Scott Med J       Date:  1965-05       Impact factor: 0.729

Review 2.  THE COAGULATION PROCESS AND GLOMERULAR DISEASE.

Authors:  P VASSALLI; R T MCCLUSKEY
Journal:  Am J Med       Date:  1965-08       Impact factor: 4.965

3.  Studies on enhanced fibrinolytic activity in man.

Authors:  S SHERRY; R I LINDEMEYER; A P FLETCHER; N ALKJAERSIG
Journal:  J Clin Invest       Date:  1959-05       Impact factor: 14.808

4.  Microangiopathic haemolytic anaemia and the pathogenesis of malignant hypertension.

Authors:  A L Linton; H Gavras; R I Gleadle; H E Hutchison; D H Lawson; A F Lever; R F Macadam; G P McNicol; J I Robertson
Journal:  Lancet       Date:  1969-06-28       Impact factor: 79.321

5.  Split products of fibrin in human renal disease.

Authors:  E R Stiehm; C W Trygstad
Journal:  Am J Med       Date:  1969-05       Impact factor: 4.965

6.  Immunochemical quantitation of antigens by single radial immunodiffusion.

Authors:  G Mancini; A O Carbonara; J F Heremans
Journal:  Immunochemistry       Date:  1965-09

7.  Inhibitors of the fibrinolytic enzyme system in renal disease.

Authors:  N B Bennett; D Ogston
Journal:  Clin Sci       Date:  1970-11       Impact factor: 6.124

8.  A method for the quantitative assay of inhibitor of plasminogen activation in human serum.

Authors:  N B Bennett
Journal:  Thromb Diath Haemorrh       Date:  1967-02-28

9.  Quantitative estimation of split products of fibrinogen in human serum, relation to diagnosis and treatment.

Authors:  C Merskey; G J Kleiner; A J Johnson
Journal:  Blood       Date:  1966-07       Impact factor: 22.113

10.  Plasma fibrinogen and plasminogen levels in health and in ischaemic heart disease.

Authors:  C M Ogston; D Ogston
Journal:  J Clin Pathol       Date:  1966-07       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.